Free US stock put/call ratio analysis and sentiment contrarian indicators for market timing signals. We monitor options market activity to understand when markets might be too bullish or bearish.
DaVita Inc. (DVA), a leading global provider of kidney care and dialysis services, is trading at a current price of $150.12 as of April 6, 2026, representing a 3.12% gain in recent trading sessions. This analysis examines key technical levels, broader sector context, and potential near-term price scenarios for the stock, with no recent earnings data available for the company as of this writing. The stock is currently trading within a well-defined near-term range, with limited company-specific ca
Is DaVita (DVA) Stock Testing Resistance | Price at $150.12, Up 3.12% - Technical Analysis
DVA - Stock Analysis
4770 Comments
1727 Likes
1
Jensine
Trusted Reader
2 hours ago
As someone who checks regularly, I’m surprised I missed it.
👍 52
Reply
2
Devaj
Elite Member
5 hours ago
I need to find others following this closely.
👍 149
Reply
3
Blaidyn
Senior Contributor
1 day ago
If only I checked one more time earlier today.
👍 65
Reply
4
Arenda
Legendary User
1 day ago
I read this and now I need a minute.
👍 164
Reply
5
Naiana
Community Member
2 days ago
Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
👍 50
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.